메뉴 건너뛰기




Volumn 75, Issue 1, 2010, Pages 70-77

Weekly paclitaxel versus weekly docetaxel in elderly or frail patients with metastatic breast carcinoma: A randomized phase-II study of the Belgian Society of Medical Oncology

Author keywords

Frail and elderly patients; Metastatic breast cancer; Taxanes

Indexed keywords

ANTHRACYCLINE DERIVATIVE; DOCETAXEL; PACLITAXEL; TAXANE DERIVATIVE; ANTINEOPLASTIC AGENT; TAXOID;

EID: 77953811582     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2009.07.001     Document Type: Review
Times cited : (22)

References (26)
  • 1
    • 24944507764 scopus 로고    scopus 로고
    • Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer
    • Jones S.E., Erban J., Overmoyer B., et al. Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer. J Clin Oncol 2005, 23:5542-5551.
    • (2005) J Clin Oncol , vol.23 , pp. 5542-5551
    • Jones, S.E.1    Erban, J.2    Overmoyer, B.3
  • 2
    • 43249115659 scopus 로고    scopus 로고
    • Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to Trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B Protocol 9840
    • Seidman A.D., Berry D., Cirrincione C., et al. Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to Trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B Protocol 9840. J Clin Oncol 2008, 26:1642-1649.
    • (2008) J Clin Oncol , vol.26 , pp. 1642-1649
    • Seidman, A.D.1    Berry, D.2    Cirrincione, C.3
  • 3
    • 0035890811 scopus 로고    scopus 로고
    • Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancer
    • Perez E., Vogel C., Irwin D., et al. Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancer. J Clin Oncol 2001, 19:4216-4223.
    • (2001) J Clin Oncol , vol.19 , pp. 4216-4223
    • Perez, E.1    Vogel, C.2    Irwin, D.3
  • 4
    • 4444264966 scopus 로고    scopus 로고
    • Weekly paclitaxel in pretreated metastatic breast cancer: retrospective analysis of 52 patients
    • Baltali E., Altundag K., Ozisik Y., et al. Weekly paclitaxel in pretreated metastatic breast cancer: retrospective analysis of 52 patients. Tohoku J Exp Med 2004, 203:205-210.
    • (2004) Tohoku J Exp Med , vol.203 , pp. 205-210
    • Baltali, E.1    Altundag, K.2    Ozisik, Y.3
  • 5
    • 0003302513 scopus 로고    scopus 로고
    • A promising second line treatment with weekly paclitaxel in anthracycline recurrent, advanced breast cancer patients
    • [abstract 515]
    • Mickiewicz E. A promising second line treatment with weekly paclitaxel in anthracycline recurrent, advanced breast cancer patients. Proc Am Soc Clin Oncol 1999, 18:135a. [abstract 515].
    • (1999) Proc Am Soc Clin Oncol , vol.18
    • Mickiewicz, E.1
  • 6
    • 0031757277 scopus 로고    scopus 로고
    • Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of advanced breast cancer
    • Seidmann A.D., Hudis C.A., Albanell J., et al. Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of advanced breast cancer. J Clin Oncol 1998, 16:3353-3361.
    • (1998) J Clin Oncol , vol.16 , pp. 3353-3361
    • Seidmann, A.D.1    Hudis, C.A.2    Albanell, J.3
  • 7
    • 0000901072 scopus 로고    scopus 로고
    • Phase II study of weekly paclitaxel treatment in recurrent breast cancer after high-dose chemotherapy
    • [abstract 245]
    • Sola C. Phase II study of weekly paclitaxel treatment in recurrent breast cancer after high-dose chemotherapy. Proc Am Soc Clin Oncol 1999, 18:65a. [abstract 245].
    • (1999) Proc Am Soc Clin Oncol , vol.18
    • Sola, C.1
  • 8
    • 0001521006 scopus 로고    scopus 로고
    • Phase II study to evaluate the efficacy of weekly paclitaxel in patients with advanced breast cancer who have failed prior anthracyclines±taxane therapy
    • [abstract 530]
    • Waintraub S.E., Cantwell S., DeVries J. Phase II study to evaluate the efficacy of weekly paclitaxel in patients with advanced breast cancer who have failed prior anthracyclines±taxane therapy. Proc Am Soc Clin Oncol 1999, 18:138a. [abstract 530].
    • (1999) Proc Am Soc Clin Oncol , vol.18
    • Waintraub, S.E.1    Cantwell, S.2    DeVries, J.3
  • 9
    • 2942525789 scopus 로고    scopus 로고
    • Taxanes in elderly breast cancer patients
    • Wildiers H., Paridaens R. Taxanes in elderly breast cancer patients. Cancer Treat Rev 2004, 30:333-342.
    • (2004) Cancer Treat Rev , vol.30 , pp. 333-342
    • Wildiers, H.1    Paridaens, R.2
  • 10
    • 0035985491 scopus 로고    scopus 로고
    • Weekly paclitaxel in women age 65 and above with metastatic breast cancer
    • Perez E.A., Vogel L., Irwin D., et al. Weekly paclitaxel in women age 65 and above with metastatic breast cancer. Breast Cancer Res Treat 2002, 73:85-88.
    • (2002) Breast Cancer Res Treat , vol.73 , pp. 85-88
    • Perez, E.A.1    Vogel, L.2    Irwin, D.3
  • 11
    • 9144259968 scopus 로고    scopus 로고
    • Weekly paclitxel as first-line chemotherapy for elderly patients with metastatic breast cancer. A multicenter phase II trial
    • Ten Tije A.J., Smorenburg C.H., Seynaeve C., et al. Weekly paclitxel as first-line chemotherapy for elderly patients with metastatic breast cancer. A multicenter phase II trial. Eur J Cancer 2004, 40:352-357.
    • (2004) Eur J Cancer , vol.40 , pp. 352-357
    • Ten Tije, A.J.1    Smorenburg, C.H.2    Seynaeve, C.3
  • 12
    • 4644357450 scopus 로고    scopus 로고
    • A multicentre, randomised phase II study of weekly or three-weekly docetaxel in patients with metastatic breast cancer
    • Tabernero J., Climent A., Lluch A., et al. A multicentre, randomised phase II study of weekly or three-weekly docetaxel in patients with metastatic breast cancer. Ann Oncol 2004, 9:1358-1365.
    • (2004) Ann Oncol , vol.9 , pp. 1358-1365
    • Tabernero, J.1    Climent, A.2    Lluch, A.3
  • 13
    • 0034061842 scopus 로고    scopus 로고
    • Docetaxel administered on a weekly basis for metastatic breast cancer
    • Burstein H.J., Manola J., Younger J., et al. Docetaxel administered on a weekly basis for metastatic breast cancer. J Clin Oncol 2000, 18:1212-1219.
    • (2000) J Clin Oncol , vol.18 , pp. 1212-1219
    • Burstein, H.J.1    Manola, J.2    Younger, J.3
  • 14
    • 0001655121 scopus 로고    scopus 로고
    • Dose dense weekly docetaxel in metastatic breast cancer
    • [abstract 527]
    • Löffler T., Dröge C., Hausamen T.U. Dose dense weekly docetaxel in metastatic breast cancer. Breast Cancer Res Treat 1999, 57:125. [abstract 527].
    • (1999) Breast Cancer Res Treat , vol.57 , pp. 125
    • Löffler, T.1    Dröge, C.2    Hausamen, T.U.3
  • 15
    • 33748476262 scopus 로고    scopus 로고
    • A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer
    • Ford H.E., Yap Y.S., Miles D., et al. A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer. Cancer Chemother Pharmacol 2006, 58:809-815.
    • (2006) Cancer Chemother Pharmacol , vol.58 , pp. 809-815
    • Ford, H.E.1    Yap, Y.S.2    Miles, D.3
  • 16
    • 0036302586 scopus 로고    scopus 로고
    • Phase II study of weekly docetaxel in patients with metastatic breast cancer
    • Aihara T., Kim Y., Takatsuka Y. Phase II study of weekly docetaxel in patients with metastatic breast cancer. Ann Oncol 2002, 13:286-292.
    • (2002) Ann Oncol , vol.13 , pp. 286-292
    • Aihara, T.1    Kim, Y.2    Takatsuka, Y.3
  • 17
    • 0035184370 scopus 로고    scopus 로고
    • Weekly docetaxel in patients with metastatic breast cancer
    • Stemmler H.J., Gutschow K., Sommer H., et al. Weekly docetaxel in patients with metastatic breast cancer. Ann Oncol 2001, 12:1393-1398.
    • (2001) Ann Oncol , vol.12 , pp. 1393-1398
    • Stemmler, H.J.1    Gutschow, K.2    Sommer, H.3
  • 18
    • 35348835960 scopus 로고    scopus 로고
    • Improvement of safety profile of docetaxel by weekly administration in patients with metastatic breast cancer
    • Warm M., Nawroth F., Ohlinger R., et al. Improvement of safety profile of docetaxel by weekly administration in patients with metastatic breast cancer. Onkologie 2007, 30:436-441.
    • (2007) Onkologie , vol.30 , pp. 436-441
    • Warm, M.1    Nawroth, F.2    Ohlinger, R.3
  • 19
    • 0001910252 scopus 로고    scopus 로고
    • Weekly docetaxel in patients with advanced malignancies. Toxicity profile and activities results
    • [abstract 453]
    • Climent M.A., Ruiz A., Llombart-Cussac A., et al. Weekly docetaxel in patients with advanced malignancies. Toxicity profile and activities results. Proc Am Soc Clin Oncol 1999, 18:119a. [abstract 453].
    • (1999) Proc Am Soc Clin Oncol , vol.18
    • Climent, M.A.1    Ruiz, A.2    Llombart-Cussac, A.3
  • 20
    • 0035424043 scopus 로고    scopus 로고
    • Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network Phase II Trial
    • Hainsworth J.D., Burris H., Yardley D., et al. Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network Phase II Trial. J Clin Oncol 2001, 19:3500-3505.
    • (2001) J Clin Oncol , vol.19 , pp. 3500-3505
    • Hainsworth, J.D.1    Burris, H.2    Yardley, D.3
  • 21
    • 1942452823 scopus 로고    scopus 로고
    • Safety and efficacy of weekly docetaxel in frail and/or elderly patients with metastatic breast cancer: a phase II study
    • D'hondt R., Paridaens R., Wildiers H., et al. Safety and efficacy of weekly docetaxel in frail and/or elderly patients with metastatic breast cancer: a phase II study. Anticancer Drugs 2004, 4:341-346.
    • (2004) Anticancer Drugs , vol.4 , pp. 341-346
    • D'hondt, R.1    Paridaens, R.2    Wildiers, H.3
  • 22
    • 0000259332 scopus 로고
    • X Ellis RE: the distribution of active bone marrow in the adult. Phys Med Biol.
    • X Ellis RE: the distribution of active bone marrow in the adult. Phys Med Biol 1961;255-8.
    • (1961) , pp. 255-8
  • 23
    • 0034594628 scopus 로고    scopus 로고
    • New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
    • February
    • Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000, 92(February(3)):205-216.
    • (2000) J Natl Cancer Inst , vol.92 , Issue.3 , pp. 205-216
    • Therasse, P.1    Arbuck, S.G.2    Eisenhauer, E.A.3
  • 24
    • 50549174560 scopus 로고
    • The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent
    • Gehan E.A. The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent. J Chron Dis 1961, 13(4):346-353.
    • (1961) J Chron Dis , vol.13 , Issue.4 , pp. 346-353
    • Gehan, E.A.1
  • 25
    • 42249083269 scopus 로고    scopus 로고
    • Weekly paclitaxel in the adjuvant treatment of breast cancer
    • Sparano J.A., Wang M., Martino S., et al. Weekly paclitaxel in the adjuvant treatment of breast cancer. N Engl J Med 2008, 358(16):1663-1671.
    • (2008) N Engl J Med , vol.358 , Issue.16 , pp. 1663-1671
    • Sparano, J.A.1    Wang, M.2    Martino, S.3
  • 26
    • 62549131714 scopus 로고    scopus 로고
    • The cancer survival gap between elderly and middle-aged patients in Europe is widening
    • Quaglia A., Tavilla A., Shack L., et al. The cancer survival gap between elderly and middle-aged patients in Europe is widening. Eur J Cancer 2009, 6:1006-1016.
    • (2009) Eur J Cancer , vol.6 , pp. 1006-1016
    • Quaglia, A.1    Tavilla, A.2    Shack, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.